Navigating the PrEP Landscape – PrEPWatch is here to help!
View this email in your browser ([link removed])
[link removed] August 2, 2024
** Navigating the PrEP Landscape – PrEPWatch is here to help!
------------------------------------------------------------
Dear Advocate,
With a growing number of PrEP products in development and approved for use in various countries, and an increase in PrEP initiations worldwide, the future of PrEP has never been more exciting. Check out our newly redesigned PrEPWatch website ([link removed]) to help navigate the latest research, policy developments, implementation strategies, and advocacy efforts worldwide. The updated site features an array of expanded PrEP resources and improved navigation. We hope PrEPWatch ([link removed]) and its resources will be helpful in your advocacy.
[link removed]
Explore the Latest on PrEPWatch
** Enhanced Resource Library ([link removed])
------------------------------------------------------------
An extensive collection of updated tools, research, and guidelines, making it easier than ever for users to access the latest information on PrEP implementation and best practices. Check out some of the most used resources like the Integrated Study Dashboard. ([link removed])
** Interactive Global PrEP Tracker ([link removed])
------------------------------------------------------------
Provides up-to-date information on PrEP initiations by country and delivery model, offering insights into the progress and impact of PrEP programs around the world.
** Country Planning Tracker ([link removed])
------------------------------------------------------------
Navigable matrix showing where PrEP products are currently approved and where approval is pending. It also tracks key indicators for the introduction of new PrEP options by country, including late-stage clinical trials and implementation research, procurement plans, and more.
** CAB for PrEP Evidence Tracker ([link removed])
------------------------------------------------------------
Summarizes the latest insights from the Biomedical Prevention Implementation Collaborative (BioPIC) on injectable CAB for PrEP, links to learn more, and information on where evidence is still needed, mapped against priority evidence gaps.
** Updated Product Pages ([link removed])
------------------------------------------------------------
Updated product information addressing frequently asked questions about PrEP options that are currently available and those in late-stage clinical development – including updates on the latest news related to injectable lenacapavir.
** Long-Acting PrEP Status Update ([link removed])
------------------------------------------------------------
Quarterly dashboard produced on behalf of the Coalition to Accelerate Access to Long-Acting PrEP ([link removed]) with graphics on regulatory approvals, volumes, ongoing and planned implementation science studies, and non-profit prices for currently available long-acting PrEP products.
The resources on PrEPWatch ([link removed]) come from projects and partners from around the world; if you have information to share or resource needs, please email
[email protected] (mailto:
[email protected]) . And we are grateful for support to AVAC from the Gates Foundation via BioPIC ([link removed]) and from PEPFAR via USAID and the Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC ([link removed]) ) project that makes PrEPWatch possible.
Best,
AVAC
P.S. Be sure to join us Monday, August 5, for our TCA webinar, Including People with Disabilities in HIV Prevention Programming and Research ([link removed]) .
[link removed]
Follow us @hivpxresearch ([link removed])
[link removed] [link removed] [link removed]
Share this issue ([link removed]) [link removed]
AVAC Global Advocacy for HIV Prevention
+1 212 796 6423
[email protected] (mailto:
[email protected]) www.avac.org ([link removed])
You're receiving this because you signed up for our newsletter. Not interested any longer?
Manage email preferences ([link removed]) | Unsubscribe ([link removed])
